(28/05/2017)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 35 | 18 | 4 / 944.4% | 7 / 1546.7% | 0 / 00% | 7 / 1546.7% | | 2 | 10 | 4 | 14 | 2 | 0 | 3 | 1 | 23 |
(21/05/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 7 | 1 / 250% | 3 / 560% | 0 / 00% | 3 / 560% | | 3 | 11 | 1 | 12 | 0 | 0 | 0 | 1 | 15 |
(07/05/2017)vs
ΠΗΓΑΣΟΣ | 00 | 5 | 3 / 742.9% | 1 / 520% | 0 / 00% | 1 / 520% | | 4 | 13 | 0 | 13 | 3 | 0 | 1 | 0 | 14 |
(22/04/2017)vs
ΠΟΛΙΤΙΣΤΙΚΟ ΚΕΝΤΡΟ ΕΡΓΑΖΟΜΕΝΩΝ Ε.ΥΔ.ΑΠ. | 00 | 13 | 1 / 250% | 6 / 966.7% | 0 / 00% | 6 / 966.7% | | 0 | 8 | 3 | 11 | 0 | 0 | 0 | 1 | 19 |
(09/04/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 0 | 0 / 00% | 0 / 00% | 0 / 00% | 0 / 00% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
(02/04/2017)vs
VITEX | 00 | 14 | 0 / 30% | 7 / 1546.7% | 0 / 00% | 7 / 1546.7% | | 1 | 12 | 3 | 15 | 3 | 1 | 0 | 2 | 20 |
(19/03/2017)vs
MINERVA MARINE | 00 | 12 | 2 / 450% | 5 / 1533.3% | 0 / 00% | 5 / 1533.3% | | 0 | 10 | 4 | 14 | 1 | 0 | 0 | 4 | 11 |
(11/03/2017)vs
ΚΑΤΣΕΛΗΣ | 00 | 8 | 0 / 10% | 4 / 850% | 0 / 00% | 4 / 850% | | 1 | 5 | 5 | 10 | 2 | 0 | 0 | 2 | 13 |
(19/02/2017)vs
ELNAVI | 00 | 17 | 1 / 1100% | 8 / 1080% | 0 / 00% | 8 / 1080% | | 1 | 6 | 2 | 8 | 1 | 1 | 0 | 2 | 23 |
(11/02/2017)vs
ΠΗΓΑΣΟΣ | 00 | 4 | 0 / 30% | 2 / 633.3% | 0 / 00% | 2 / 633.3% | | 1 | 12 | 3 | 15 | 2 | 0 | 0 | 2 | 12 |
(28/01/2017)vs
ΠΟΛΙΤΙΣΤΙΚΟ ΚΕΝΤΡΟ ΕΡΓΑΖΟΜΕΝΩΝ Ε.ΥΔ.ΑΠ. | 00 | 19 | 1 / 250% | 9 / 1464.3% | 0 / 00% | 9 / 1464.3% | | 3 | 9 | 2 | 11 | 2 | 0 | 0 | 0 | 26 |
(22/01/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 6 | 0 / 00% | 3 / 742.9% | 0 / 10% | 3 / 837.5% | | 2 | 4 | 0 | 4 | 0 | 0 | 0 | 1 | 4 |
(14/01/2017)vs
VITEX | 00 | 0 | 0 / 00% | 0 / 00% | 0 / 00% | 0 / 00% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
(18/12/2016)vs
MINERVA MARINE | 16 | 6 | 0 / 00% | 3 / 837.5% | 0 / 00% | 3 / 837.5% | | 0 | 10 | 2 | 12 | 1 | 0 | 1 | 1 | 14 |
(11/12/2016)vs
ΚΑΤΣΕΛΗΣ | 00 | 2 | 0 / 00% | 1 / 333.3% | 0 / 00% | 1 / 333.3% | | 1 | 5 | 1 | 6 | 1 | 0 | 1 | 2 | 6 |
(27/11/2016)vs
OMS | 00 | 0 | 0 / 00% | 0 / 30% | 0 / 00% | 0 / 30% | | 0 | 2 | 1 | 3 | 0 | 1 | 0 | 1 | 0 |
(13/11/2016)vs
OMS | 00 | 0 | 0 / 00% | 0 / 00% | 0 / 00% | 0 / 00% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
(06/11/2016)vs
PHARMACIA | 28 | 8 | 0 / 00% | 4 / 850% | 0 / 10% | 4 / 944.4% | | 5 | 8 | 2 | 10 | 3 | 1 | 0 | 0 | 17 |
(16/10/2016)vs
OMS | 00 | 9 | 1 / 250% | 4 / 666.7% | 0 / 00% | 4 / 666.7% | | 2 | 5 | 1 | 6 | 1 | 0 | 0 | 0 | 13 |
(02/10/2016)vs
ΚΑΤΣΕΛΗΣ | 30 | 12 | 1 / 333.3% | 4 / 944.4% | 1 / 1100% | 5 / 1050% | | 2 | 4 | 2 | 6 | 1 | 2 | 0 | 2 | 12 |
| ΣΥΝΟΛΙΚΑ |
109 |
160 |
15 / 3938.5% |
71 / 14648.6% |
1 / 333.3% |
72 / 14948.3% |
|
28 |
134 |
36 |
170 |
23 |
6 |
6 |
22 |
242 |
| ΜΕΣΟΙ ΟΡΟΙ |
5.4 |
8 |
0.8 / 2.038.5% |
3.6 / 7.348.6% |
0.0 / 0.233.3% |
3.6 / 7.448.3% |
|
1.4 |
6.7 |
1.8 |
8.5 |
1.2 |
0.3 |
0.3 |
1.1 |
12.1 |